Cargando…

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness

BACKGROUND: Shorter, safer, and cheaper tuberculosis (TB) preventive treatment (TPT) regimens will enhance uptake and effectiveness. WHO developed target product profiles describing minimum requirements and optimal targets for key attributes of novel TPT regimens. We performed a cost-effectiveness a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nsengiyumva, Ntwali Placide, Campbell, Jonathon R., Oxlade, Olivia, Vesga, Juan F., Lienhardt, Christian, Trajman, Anete, Falzon, Dennis, Den Boon, Saskia, Arinaminpathy, Nimalan, Schwartzman, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239450/ https://www.ncbi.nlm.nih.gov/pubmed/35696431 http://dx.doi.org/10.1371/journal.pmed.1004032

Ejemplares similares

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
por: Vesga, Juan F., et al.
Publicado: (2022)

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2018)

The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities
por: N’Diaye, Dieynaba S., et al.
Publicado: (2019)

Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)

The impact of digital health technologies on tuberculosis treatment: a systematic review
por: Ngwatu, Brian Kermu, et al.
Publicado: (2018)

Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2021)

Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
por: Steffen, Ricardo, et al.
Publicado: (2010)

WHO target product profiles for TB preventive treatment
por: Den Boon, S., et al.
Publicado: (2022)

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
por: Campbell, Jonathon R., et al.
Publicado: (2022)

Active screening for tuberculosis in high-incidence Inuit communities in Canada: a cost-effectiveness analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI
por: Oxlade, Olivia, et al.
Publicado: (2013)

Factors associated with the rapid implementation process of the fixed-dose combination RHZE tuberculosis regimen in brazil: an ecological study
por: Braga, José Ueleres, et al.
Publicado: (2013)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
por: Jacquet, Vary, et al.
Publicado: (2006)

Xpert®MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation
por: Oxlade, Olivia, et al.
Publicado: (2016)

Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
por: Arinaminpathy, Nimalan, et al.
Publicado: (2021)

Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
por: Steffen, Ricardo E., et al.
Publicado: (2020)

Hepatitis B Screening and Vaccination Strategies for Newly Arrived Adult Canadian Immigrants and Refugees: A Cost-Effectiveness Analysis
por: Rossi, Carmine, et al.
Publicado: (2013)

Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis
por: Silva, Sachin, et al.
Publicado: (2021)

The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading
por: Moayedi-Nia, Saeedeh, et al.
Publicado: (2019)

Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System
por: Pinto, Márcia, et al.
Publicado: (2015)

Cost-Effectiveness of Quantiferon®-TB Gold-In-Tube Versus Tuberculin Skin Testing for Contact Screening and Treatment of Latent Tuberculosis Infection in Brazil
por: Steffen, Ricardo Ewbank, et al.
Publicado: (2013)

Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study
por: Braga, José Ueleres, et al.
Publicado: (2015)

Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services
por: Trajman, Anete, et al.
Publicado: (2016)

Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs
por: Oxlade, Olivia, et al.
Publicado: (2015)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

Can Brazil play a more important role in global tuberculosis drug production? An assessment of current capacity and challenges
por: Gemal, Andre, et al.
Publicado: (2013)

Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2010)

The impact of the COVID-19 pandemic in tuberculosis preventive treatment in Brazil: a retrospective cohort study using secondary data
por: Coutinho, Iane, et al.
Publicado: (2023)

Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
por: Oxlade, Olivia, et al.
Publicado: (2021)

GeneXpert or chest-X-ray or tuberculin skin testing for household contact assessment (GXT): protocol for a cluster-randomized trial
por: Trajman, Anete, et al.
Publicado: (2022)

Framework for the evaluation of new tests for tuberculosis infection
por: Hamada, Yohhei, et al.
Publicado: (2021)

Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis
por: Ricks, Saskia, et al.
Publicado: (2020)

The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2021)

The effects of a partitioned var gene repertoire of Plasmodium falciparum on antigenic diversity and the acquisition of clinical immunity
por: Recker, Mario, et al.
Publicado: (2008)

Effective use of a Limited Antiviral Stockpile for Pandemic Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_47somk7iafbq6q24canasbcmol